Grant: Discovery Grants Program - Individual
University of Toronto
$41,000.00
Discovery of novel metabolites using click-chemistry tools
EF 2021-22
Résumé
Mass spectrometry (MS)-based metabolomics is an emerging field focused on the profiling of small, naturally occurring molecules collectively known as the "metabolome". Metabolomics provides a powerful strategy to understand and investigate quantitative changes associated with a unique phenotype at the molecular level. Specifically, the relatively novel approach of untargeted metabolomics provides a comprehensive systems-wide view of metabolites or pathways with direct functional consequences. However, compared to hypothesis-driven targeted approaches, untargeted approaches are hampered by difficulties in exact compound identification, issues with limited compound abundance in samples, and low interpretability with respect to biological significance. These limitations become more challenging in the case of unknown metabolites (the "dark metabolome"), which account for ~90% of detected compounds, leaving thousands of compounds that remain to be catalogued and potentially linked to biologically significant phenotypes. My research program is aimed at discovering and mapping unknown endogenous metabolites in living organisms and determining their biosynthesis and function. Here we propose to expand the metabolome coverage and discovery in untargeted metabolomics by developing a novel systematic approach based on innovative click-chemistry metabolic labeling for metabolite enrichment. This will allow systematic mapping of target pathways, identify new and low abundance metabolites and elucidate the biosynthesis of interesting metabolites. Aim 1: Develop an optimize click-chemistry tools and resources to tag, enrich and subsequently identify novel metabolic species. Aim 2: Map the sphingolipidome in eukaryotic metabolism and annotate new metabolic species. Aim 3: Determine the substrate and products of orphan and poorly annotated enzymes. The potential impact of this research is a crucial improvement in the metabolome coverage. It will enhance our ability to explore and map metabolic pathways and discover novel metabolic species and networks. The anticipated result of this research lies in an improved methodology to specifically enrich metabolites in targeted pathways and remove interfering molecules. The impact will range from basic research and understanding of metabolism to identifying targets for therapeutical treatments.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2021-03993
Name nom
Montenegro Burke, J. Rafael
Department département
Donnelly Centre for Cellular & Biomolecular Research
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Installment
inst:1
Partie
1
Nb partie
5
Application title
Discovery of novel metabolites using click-chemistry tools
Keyword
NSERC
Application summary
Mass spectrometry (MS)-based metabolomics is an emerging field focused on the profiling of small, naturally occurring molecules collectively known as the "metabolome". Metabolomics provides a powerful strategy to understand and investigate quantitative changes associated with a unique phenotype at the molecular level. Specifically, the relatively novel approach of untargeted metabolomics provides a comprehensive systems-wide view of metabolites or pathways with direct functional consequences. However, compared to hypothesis-driven targeted approaches, untargeted approaches are hampered by difficulties in exact compound identification, issues with limited compound abundance in samples, and low interpretability with respect to biological significance. These limitations become more challenging in the case of unknown metabolites (the "dark metabolome"), which account for ~90% of detected compounds, leaving thousands of compounds that remain to be catalogued and potentially linked to biologically significant phenotypes. My research program is aimed at discovering and mapping unknown endogenous metabolites in living organisms and determining their biosynthesis and function. Here we propose to expand the metabolome coverage and discovery in untargeted metabolomics by developing a novel systematic approach based on innovative click-chemistry metabolic labeling for metabolite enrichment. This will allow systematic mapping of target pathways, identify new and low abundance metabolites and elucidate the biosynthesis of interesting metabolites. Aim 1: Develop an optimize click-chemistry tools and resources to tag, enrich and subsequently identify novel metabolic species. Aim 2: Map the sphingolipidome in eukaryotic metabolism and annotate new metabolic species. Aim 3: Determine the substrate and products of orphan and poorly annotated enzymes. The potential impact of this research is a crucial improvement in the metabolome coverage. It will enhance our ability to explore and map metabolic pathways and discover novel metabolic species and networks. The anticipated result of this research lies in an improved methodology to specifically enrich metabolites in targeted pathways and remove interfering molecules. The impact will range from basic research and understanding of metabolism to identifying targets for therapeutical treatments.